Ocular Therapeutix
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell OCUL and other ETFs, options, and stocks.About OCUL
Ocular Therapeutix, Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapies for diseases and conditions of the eye. Its product pipeline includes Dextenza, OTX-TP, and OTX-TIC.
CEOPravin U. Dugel
CEOPravin U. Dugel
Employees274
Employees274
HeadquartersBedford, Massachusetts
HeadquartersBedford, Massachusetts
Founded2006
Founded2006
Employees274
Employees274
OCUL Key Statistics
Market cap1.28B
Market cap1.28B
Price-Earnings ratio-7.09
Price-Earnings ratio-7.09
Dividend yield—
Dividend yield—
Average volume1.77M
Average volume1.77M
High today$8.15
High today$8.15
Low today$7.62
Low today$7.62
Open price$8.08
Open price$8.08
Volume2.13M
Volume2.13M
52 Week high$11.78
52 Week high$11.78
52 Week low$4.79
52 Week low$4.79
OCUL News
Simply Wall St 2d
Ocular Therapeutix Has Debt But No Earnings; Should You Worry?Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of permanent loss is the risk I worry about......
Analyst ratings
100%
of 13 ratingsBuy
100%
Hold
0%
Sell
0%
People also own
Based on the portfolios of people who own OCUL. This list is generated using Robinhood data, and it’s not a recommendation.